With the purchase of Aetna, CVS hopes to steer patients enrolled in Aetna’s insurance plans from hospital outpatient clinics and go directly to clinics located inside the CVS retail outlets.
Regulations impacting hospitals that acquire their drugs through the 340B drug discount program took effect Jan. 1. The program allows certain not-for-profit hospitals to purchase drugs at a reduced price.
Hospitals now face a double hit. Not only are payments for separately payable drugs being slashed, but pharmacies are looking to take emergency and other outpatient services away from hospitals by providing the services in their retail outlets.
Large box pharmacies have dominated the market providing drugs to hospitals enrolled in the 340B drug program. Currently, Walgreens holds almost one-third of the total 340B market, with CVS running a distant second. With high reimbursement rates, it has been a lucrative business for the drug giants. The cuts to the 340B drug program have put a big dent in profits. CVS came up with a solution – and a way to take business from Walgreens.
It is all about taking services from hospitals – there is no need to get profits from just selling drugs after the cuts to the 340B drug program.
CVS and Aetna also recently announced the intention for the pharmacy giant to purchase the insurance company for $69 billion.
It is part of a long-range business strategy to change how healthcare is provided in the United States. CVS would use its massive retail network to provide services to people enrolled in Aetna’s insurance plans.
CVS would like millions of patients going to hospital emergency rooms to get services from CVS clinics; yet this marks a particularly big hit to rural critical access hospitals required to maintain emergency room services. Patients who might have gone to their local hospital will instead go to their 24-hour CVS pharmacy to see doctors and fill their prescriptions. With the purchase of Aetna, they can also steer patients enrolled in Aetna’s insurance plans from hospital outpatient clinics and go directly to clinics located inside the CVS retail outlets.
It would seem that if the merger of CVS and Aetna can move forward, it will be a matter of time before Walgreens moves to purchase an insurance partner. Both Walgreens and Walmart are already eyeing Humana, which is currently playing a spoiler in Walgreens’ recent attempt to purchase Rite-Aid.
It would be sweet revenge for Walgreens to purchase Humana.
Stay safe out there.
Is the membership of PHARMA.org made up almost exclusively by companies that sell high priced drugs and devices? Unless you live under a rock, you
The Supreme Court ruling strikes down Medicare payment cuts. On June 15, the U.S. Supreme Court sided with hospital groups in a case challenging the 340B payment
Please log in to your account to comment on this article.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.
Fraud convictions don’t just punish a few bad claims; they can wipe out years of reimbursements. Don’t wait for an audit to learn the rules. Join Frank Cohen, MPA, for a live Q&A on spotting red flags, avoiding liability, and protecting your practice. Register now and bring your questions!
Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025. Register today and be a part of the conversation!
Copyright © 2025 ICD10monitor. Powered by MedLearn Media.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
